Search
Become a Member
US Equestrian offices will be closed on Thursday, July 4th, in observance of Independence Day
  1. Home
  2. Network & News
  3. Press Releases
  4. Article
  • Share:

Voice Your Views on Medroxyprogesterone Acetate (Depo-Provera®) for Competition Horses at Public Workshop

US Equestrian Federation Considering Rule Changes Regarding the Use of Depo-Provera® at USEF-Licensed Competitions

by US Equestrian Communications Department | Mar 6, 2017, 5:35 PM

Lexington, Ky. - Consistent with its goal of transparency and good governance, the United States Equestrian Federation (USEF) will openly review the science and use of Medroxyprogesterone Acetate (Depo-Provera®) in competition horses during a public workshop on Monday, March 13, in Orlando, Fla. Your participation is essential in helping the USEF determine if it is necessary to change the rules regarding the use of this substance at USEF licensed competitions. The USEF will provide members, stakeholders, and industry experts two ways to participate.

  • Through the moderated, public workshop: an expert panel will hear presentations from you, the membership, as well as industry experts, prior to making a report to the Board of Directors at its Mid-Year Meeting. This will be a presentation format rather than a Q&A so that the panelists may focus on listening to the membership and the science.
  • Through written comments: comments may be submitted by emailing [email protected] and received by the USEF no later than one week following the public workshop. 

Medroxyprogesterone Acetate (Depo-Provera®) Fast Facts:

  • Depo-Provera® was created and developed for use in women for the prevention of pregnancy.
  • USEF has heard from its  members that they administer Depo-Provera® as a substitute for Regumate®.
  • Scientific research demonstrates that Depo-Provera® does not produce the same effect in horses as it does in humans.
  • Anecdotal evidence suggests that Depo-Provera® has a calming effect on horses. 

Event Details

  • What: Public workshop on the use of Medroxyprogesterone Acetate (Depo-Provera®)
  • Why: To address concerns about the efficacy, safety, and use of this substance in competition horses.
  • Where: Orlando Airport Marriott Lakeside Hotel in Orlando, Fla.
  • When: March 13, 2017 from 1:00 pm to 5:00 pm EST
  • How: Register by emailing [email protected]. Due to limited space, only registered attendees (including press) will be permitted. If you are interested in presenting, you will be required to identify your area of focus (e.g. trainer, veterinarian, owner, competitor, manufacturer, scientist) and provide a short description of what topics or concerns your comments will address.

For those members who are unable to attend, the public workshop will be live streamed on the USEF Network.
 
For additional information or general inquiries, please visit the 2017 Workshop webpage or email [email protected].